Published in Nephrol Dial Transplant on January 23, 2012
Kidney disease and multiple myeloma. Clin J Am Soc Nephrol (2013) 1.26
Myeloma kidney: advances in molecular mechanisms of acute kidney injury open novel therapeutic opportunities. Nephrol Dial Transplant (2012) 0.82
Multiple myeloma and kidney disease. ScientificWorldJournal (2013) 0.80
Paraprotein-Related Kidney Disease: Evaluation and Treatment of Myeloma Cast Nephropathy. Clin J Am Soc Nephrol (2016) 0.80
Novel approaches for reducing free light chains in patients with myeloma kidney. Nat Rev Nephrol (2012) 0.80
Effectiveness of Haemodiafiltration with Heat Sterilized High-Flux Polyphenylene HF Dialyzer in Reducing Free Light Chains in Patients with Myeloma Cast Nephropathy. PLoS One (2015) 0.78
Current Trends of Renal Impairment in Multiple Myeloma. Kidney Dis (Basel) (2016) 0.77
The role of technological progress vs. accidental discoveries and clinical experience. Med Sci Monit (2013) 0.77
Acute kidney injury in critically ill cancer patients: an update. Crit Care (2016) 0.75
Therapeutic Efficacy and Cost Effectiveness of High Cut-Off Dialyzers Compared to Conventional Dialysis in Patients with Cast Nephropathy. PLoS One (2016) 0.75
Impact of High-Cut-Off Dialysis on Renal Recovery in Dialysis-Dependent Multiple Myeloma Patients: Results from a Case-Control Study. PLoS One (2016) 0.75
Percentage of urinary albumin excretion and serum-free light-chain reduction are important determinants of renal response in myeloma patients with moderate to severe renal impairment. Blood Cancer J (2014) 0.75
Enhancing dialyser clearance-from target to development. Pediatr Nephrol (2017) 0.75
Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst (2004) 3.11
Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med (2005) 3.09
Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML). Blood (2012) 2.39
Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease. Clin J Am Soc Nephrol (2008) 2.08
The role of capillary density, macrophage infiltration and interstitial scarring in the pathogenesis of human chronic kidney disease. Kidney Int (2008) 1.94
Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant. Blood (2012) 1.75
A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine. Int J Cancer (2003) 1.61
Immunohistochemical detection of hypoxia-inducible factor-1alpha in human renal allograft biopsies. J Am Soc Nephrol (2006) 1.61
Pentraxin 3 is elevated in haemodialysis patients and is associated with cardiovascular disease. Nephrol Dial Transplant (2007) 1.57
Early reduction of serum-free light chains associates with renal recovery in myeloma kidney. J Am Soc Nephrol (2011) 1.57
Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies. J Am Soc Nephrol (2007) 1.54
Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy. J Clin Neurosci (2004) 1.51
The genetic predisposition of natural killer cell to BK virus-associated nephropathy in renal transplant patients. Kidney Int (2013) 1.44
Macrophages and progressive tubulointerstitial disease. Kidney Int (2005) 1.40
Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure. BMC Nephrol (2008) 1.39
Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation. Kidney Int (2008) 1.36
Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis. Clin J Am Soc Nephrol (2009) 1.30
Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry. Nephrol Dial Transplant (2012) 1.29
The biology of immunoglobulin free light chains and kidney injury. Kidney Int (2011) 1.27
EEG source localization in focal epilepsy: where are we now? Epilepsia (2007) 1.22
Hyperosmotic stress enhances cytokine production and decreases phagocytosis in vitro. Crit Care (2008) 1.18
Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia. Haematologica (2009) 1.17
Magnetic resonance imaging study in older fragile X premutation male carriers. Ann Neurol (2005) 1.16
Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials. BMJ (2003) 1.12
Cancer in Canada in 2008. CMAJ (2008) 1.11
Lack of increased colonization with vancomycin-resistant enterococci during preferential use of vancomycin for treatment during an outbreak of healthcare-associated Clostridium difficile infection. Infect Control Hosp Epidemiol (2010) 1.09
Association of caveolin-1 gene polymorphism with kidney transplant fibrosis and allograft failure. JAMA (2010) 1.07
CD248+ stromal cells are associated with progressive chronic kidney disease. Kidney Int (2011) 1.04
Meta-analysis of calcineurin-inhibitor-sparing regimens in kidney transplantation. J Am Soc Nephrol (2011) 1.04
Serum free-light chain removal by high cutoff hemodialysis: optimizing removal and supportive care. Artif Organs (2008) 1.04
Renal TLR4 mRNA expression correlates with inflammatory marker MCP-1 and profibrotic molecule TGF-β₁ in patients with chronic kidney disease. Nephron Clin Pract (2011) 1.00
Australian pregnancy registry of women taking antiepileptic drugs. Epilepsia (2004) 0.99
Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria. Circulation (2005) 0.99
Effect of pamidronate on bone loss after kidney transplantation: a randomized trial. Am J Kidney Dis (2009) 0.98
Donor ABCB1 variant associates with increased risk for kidney allograft failure. J Am Soc Nephrol (2012) 0.98
Serum free light chain assessment in monoclonal gammopathy and kidney disease. Nat Rev Nephrol (2009) 0.98
Determining the safety of enzymes used in animal feed. Regul Toxicol Pharmacol (2009) 0.97
A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma. Br J Haematol (2012) 0.97
Ruptured arterial aneurysm of the kidney in a patient with Wegener's granulomatosis. Nephrol Dial Transplant (2003) 0.97
Amoxicillin-induced acute renal failure. Nephrol Dial Transplant (2003) 0.96
Proteasome inhibition by bortezomib: effect on HLA-antibody levels and specificity in sensitized patients awaiting renal allograft transplantation. Transpl Immunol (2012) 0.95
European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE): a randomised control trial. Trials (2008) 0.94
Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome. Nephrol Dial Transplant (2002) 0.92
Preoperative evaluation of living kidney donors using multirow detector computed tomography: comparison with digital subtraction angiography and intraoperative findings. Transpl Int (2005) 0.91
Plasma profiling reveals human fibulin-1 as candidate marker for renal impairment. J Proteome Res (2011) 0.90
Identification of the optimal donor quality scoring system and measure of early renal function in kidney transplantation. Transplantation (2009) 0.90
Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma. Br J Haematol (2009) 0.90
Long-term results of subtotal vs total parathyroidectomy without autotransplantation in kidney transplant recipients. Arch Surg (2008) 0.90
Adverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort study. BMC Musculoskelet Disord (2010) 0.90
Bone morphogenic protein-4 expression in vascular lesions of calciphylaxis. J Nephrol (2004) 0.89
Rhabdomyolysis and acute kidney injury. N Engl J Med (2009) 0.89
Rhabdomyolysis and acute kidney injury. N Engl J Med (2009) 0.89
Controlled delivery for neuro-bionic devices. Adv Drug Deliv Rev (2012) 0.89
Resolution of cast nephropathy following free light chain removal by haemodialysis in a patient with multiple myeloma: a case report. J Med Case Rep (2008) 0.89
Practical recommendations for the early use of m-TOR inhibitors (sirolimus) in renal transplantation. Transpl Int (2009) 0.88
Assessing and comparing rival definitions of delayed renal allograft function for predicting subsequent graft failure. Transplantation (2010) 0.88
Novel approach for improved assessment of phenotypic and functional characteristics of BKV-specific T-cell immunity. Transplantation (2011) 0.88
Calcineurin inhibitor sparing with mycophenolate in kidney transplantation: a systematic review and meta-analysis. Transplantation (2009) 0.88
The incidence of major hemorrhagic complications after renal biopsies in patients with monoclonal gammopathies. Clin J Am Soc Nephrol (2010) 0.88
The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol. BMC Nephrol (2013) 0.87
Global expression profiling in epileptogenesis: does it add to the confusion? Brain Pathol (2009) 0.87
Aggregated serum free light chains may prevent adequate removal by high cut-off haemodialysis. Nephrol Dial Transplant (2011) 0.86
Serum free light chains and the risk of ESRD and death in CKD. Clin J Am Soc Nephrol (2011) 0.86
Quantitative assessment of serum and urinary polyclonal free light chains in patients with type II diabetes: an early marker of diabetic kidney disease? Expert Opin Ther Targets (2008) 0.86
Ulcerative dermatitis in C57BL/6 mice lacking stearoyl CoA desaturase 1. Comp Med (2012) 0.86
Depression in temporal lobe epilepsy surgery patients: an FDG-PET study. Epilepsia (2006) 0.85
Comparison of the predictive performance of eGFR formulae for mortality and graft failure in renal transplant recipients. Transplantation (2009) 0.85
A quantitative survey of Western Muslim attitudes to solid organ donation. Transplantation (2011) 0.85
Mortality prediction after kidney transplantation: comparative clinical use of 7 comorbidity indices. Exp Clin Transplant (2011) 0.84
Does immunosuppressant medication lower blood pressure and arterial stiffness in patients with chronic kidney disease? An observational study. Hypertens Res (2010) 0.84
Survival and transplantation in end-stage renal disease: a prospective study of a multiethnic population. Nephrol Dial Transplant (2009) 0.84
The prognosis of idiopathic generalized epilepsy. Epilepsia (2012) 0.84
C-reactive-protein and cytokine plasma levels in hemodialysis patients. J Nephrol (2002) 0.84
Organ trafficking for live donor kidney transplantation in Indoasians resident in the west midlands: high activity and poor outcomes. Transplantation (2010) 0.83
Differential progression of renal scarring and determinants of late renal recovery in sustained dialysis dependent acute kidney injury secondary to myeloma kidney. J Clin Pathol (2010) 0.83
Elevated FOSB-expression; a potential marker of valproate sensitivity in AML. Br J Haematol (2008) 0.83
A novel bio-assay increases the detection yield of microbiological impurity of dialysis fluid, in comparison to the LAL-test. Nephrol Dial Transplant (2008) 0.83
Association of the MELAS m.3243A>G mutation with myositis and the superiority of urine over muscle, blood and hair for mutation detection. J Clin Neurosci (2009) 0.83
Development and evaluation of a composite risk score to predict kidney transplant failure. Am J Kidney Dis (2011) 0.82
Re-transplantation after bortezomib-based therapy. Br J Haematol (2011) 0.82
KIR and HLA-C interactions promote differential dendritic cell maturation and is a major determinant of graft failure following kidney transplantation. PLoS One (2011) 0.81
The impact of hemoglobin levels on patient and graft survival in renal transplant recipients. Transplantation (2008) 0.81
A Microsoft-Excel-based tool for running and critically appraising network meta-analyses--an overview and application of NetMetaXL. Syst Rev (2014) 0.81
Focal abnormalities in idiopathic generalized epilepsy: a critical review of the literature. Epilepsia (2014) 0.81
Optimising the accuracy of blood pressure monitoring in chronic kidney disease: the utility of BpTRU. BMC Nephrol (2013) 0.81
The impact of chronic kidney disease and cardiovascular comorbidity on mortality in a multiethnic population: a retrospective cohort study. BMJ Open (2013) 0.81
The genotype of RAET1L (ULBP6), a ligand for human NKG2D (KLRK1), markedly influences the clinical outcome of allogeneic stem cell transplantation. Br J Haematol (2012) 0.81
Comprehensive assessment of renal function and vessel morphology in potential living kidney donors: an MRI-based approach. Invest Radiol (2009) 0.81